This year has brought important changes to New Jersey’s Medicinal Marijuana Program and Columbia Care is excited to announce that we’ll soon be serving patients in the Garden State:
NEW YORK, Dec. 18, 2018 — Columbia Care LLC (“Columbia Care”), one of the nation’s leading medical cannabis companies, today announced that, after a rigorous vetting and selection process, it is one of six applicants chosen by the New Jersey Department of Health to apply for a permit to cultivate, process and dispense cannabinoid-based products to qualifying patients. The vertically integrated Columbia Care New Jersey Alternative Treatment Center (ATC) will be based in Vineland and, upon completion of final regulatory steps, will serve patients throughout the state.
“We are proud and grateful to be one of only six new ATCs chosen through the New Jersey Department of Health’s rigorous selection process to cultivate, manufacture and dispense medical cannabis products in New Jersey,” said Nicholas Vita, chief executive officer of Columbia Care. “The priorities of service and caring are the bedrock foundation of our organization. Being given the opportunity to strengthen the health and economic vitality of the Vineland community, while addressing unmet medical needs of patients throughout New Jersey, is part and parcel with the mission and purpose of our organization and reaffirms our position as the dominant national medical cannabis operator in highly selective, highly regulated jurisdictions. We look forward to providing validated and patented pharmaceutical- quality medicines to qualifying patients throughout the Garden State as we launch our vertically integrated operations in 2019. Consistent with our efforts globally, in particular, the 13 other states and territories where we operate in the United States, our cultivation and manufacturing facility will be state-of-the-art, and our dispensary and products will uphold the tradition of all Columbia Care locations by ensuring the highest levels of patient experience and satisfaction while offering the best selection of nationally-branded and patented products.” [Columbia Care]
We’re honored by this opportunity and proud to have secured approval through such a selective process. The Medicinal Marijuana Program’s expansion represents a long-awaited opportunity for New Jersey patients to access a broader range of treatment options. We’re confident that our curated product line and comfortable facility will help improve quality of life for patients in Vineland and throughout the State. Please visit Columbia Care NJ for updates as we work towards opening our doors in the Garden State.